Provided by Tiger Trade Technology Pte. Ltd.

SciSparc Ltd.

4.55
-0.1700-3.60%
Pre-market: 4.550.00000.00%07:00 EDT
Volume:1K
Turnover:6.72K
Market Cap:2.64M
PE:-0.05
High:4.55
Open:4.55
Low:4.55
Close:4.72
52wk High:48.33
52wk Low:2.98
Shares:581.00K
Float Shares:561.10K
Volume Ratio:0.05
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-98.0714
EPS(LYR):-98.0714
ROE:-315.62%
ROA:-66.94%
PB:0.67
PE(LYR):-0.05

Loading ...

Scisparc Ltd trading halted, volatility trading pause

TIPRANKS
·
Jul 29

SciSparc Targets Agentic AI Market as New Growth Strategy

Reuters
·
Jul 29

SciSparc Subsidiary NeuroThera Labs Validates Quantum Sampling Workflow for Clinical Trials Analytics Platform

Reuters
·
Jul 29

Scisparc Announces Decision to Target the Agentic AI Market; Forms Scientific Advisory Board for Artificial Intelligence and Cybersecurity

THOMSON REUTERS
·
Jul 27

Scisparc - in Discussions with Companies in Agentic AI Field

THOMSON REUTERS
·
Jul 27

SciSparc initiates SCI-110 clinical trial in Germany

TIPRANKS
·
Jul 15

Scisparc: Neurothera Labs Announces Initiation of Phase Iib Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome

THOMSON REUTERS
·
Jul 15

Scisparc Unit Neurothera Labs Starts Phase Iib Tourette Trial Site at Hannover Medical School

Reuters
·
Jul 15

Neurothera Labs Targets up to C$ 5 Million in Private Placement of Units at C$ 0.135 Each

Reuters
·
Jul 01

SciSparc unit NeuroThera closes purchase of 54% stake in CliniQuantum for CAD 9.46 million in shares

Reuters
·
Jun 04

Scisparc: Subsidiary Neurothera Labs Completed Acquisition of Cliniquantum

THOMSON REUTERS
·
Jun 04

SciSparc director Itschak Shrem sells 462 shares for $4,620

Reuters
·
Jun 03

BUZZ-U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's

Reuters
·
May 29

Why Is SciSparc Stock Skyrocketing On Thursday?

Benzinga
·
May 29

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM

Reuters
·
May 28

SciSparc unit NeuroThera wins conditional TSX approval for CliniQuantum acquisition update

Reuters
·
May 28

Scisparc: Subsidiary Neurothera Labs Received Conditional Regulatory Approval for Acquisition of Cliniquantum

THOMSON REUTERS
·
May 28

SciSparc regains Nasdaq equity compliance, avoids delisting for now

Reuters
·
May 11

Scisparc FY25 net loss widens 94% to USD 12.18 million

Reuters
·
Apr 30